Pharmacotherapy for allergic rhinitis

Thuy-Anh N Melvin; Alpen A Patel

doi:10.1016/j.otc.2011.03.010

Pharmacotherapy for allergic rhinitis

Otolaryngol Clin North Am. 2011 Jun;44(3):727-39, x. doi: 10.1016/j.otc.2011.03.010. Epub 2011 May 2.

Authors

Thuy-Anh N Melvin¹, Alpen A Patel

Affiliation

¹ Johns Hopkins Department of Otolaryngology-Head and Neck Surgery, Baltimore, MD 21287, USA. tamelvin@gmail.com

PMID: 21621057
DOI: 10.1016/j.otc.2011.03.010

Abstract

Allergic rhinitis affects millions of Americans and the numbers continue to increase. Fortunately, there exists a wide array of pharmacotherapeutic options with relatively safe side effect profiles for the management of the varying subtypes. Additionally, there are newer agents on the horizon. The efficacies of intranasal corticosteroids, antihistamines, combination topical therapy, leukotriene inhibitors, mast cell stabilizers, anticholinergics, mucolytics, decongestants, and anti-IgE are reviewed.

Publication types

Review

MeSH terms

Administration, Intranasal
Anti-Allergic Agents / therapeutic use
Antibodies, Anti-Idiotypic / therapeutic use
Cholinergic Antagonists / therapeutic use
Cromolyn Sodium / therapeutic use
Drug Therapy, Combination
Expectorants / therapeutic use
Glucocorticoids / administration & dosage
Histamine Antagonists / therapeutic use
Humans
Immunoglobulin E
Leukotriene Antagonists / therapeutic use
Nasal Decongestants / therapeutic use
Rhinitis, Allergic, Perennial / drug therapy*
Rhinitis, Allergic, Seasonal / drug therapy*

Substances

Anti-Allergic Agents
Antibodies, Anti-Idiotypic
Cholinergic Antagonists
Expectorants
Glucocorticoids
Histamine Antagonists
Leukotriene Antagonists
Nasal Decongestants
anti-IgE antibodies
Immunoglobulin E
Cromolyn Sodium